Multiple Myeloma

Multiple Myeloma News

  • Transplantation for Myeloma Patients -- Can It Wait? Following induction, PFS and response rates are higher for myeloma patients when transplant is part of consolidation therapy. Survival is similar to that in patients receiving transplant after relapse.
  • 'DaraLenDex' Combo Best for Relapsed/Refractory Multiple Myeloma The combination of daratumumab, lenalidomide and dexamethasone (DaraLenDex) appears to offer the best outcomes in patients with relapsed and/or refractory multiple myeloma (MM), according to a network meta-analysis involving 18 treatment options.
 

Multiple Myeloma Perspective

 

Journals